Showing results (1-10 of 126) with videos related to
Sort By:
Pageof 13
European Journal of Haematology|February 28, 2002
Prevalence of retinopathy in patients with anemia or thrombocytopeniaM C Carraro, L Rossetti, G C GerliBest Practice & Research. Clinical Haematology|March 2, 2005
Iron-chelating therapy with the new oral agent ICL670 (Exjade)M D CappelliniLancet (London, England)|January 8, 2008
Glucose-6-phosphate dehydrogenase deficiencyM D Cappellini, G FiorelliActa Haematologica|November 13, 2009
Deferasirox (Exjade) for the treatment of iron overloadM D Cappellini, A TaherExpert Opinion on Pharmacotherapy|August 20, 2008
Long-term experience with deferasirox (ICL670), a once-daily oral iron chelator, in the treatment of transfusional iron overloadM D Cappellini, A TaherExperientia|April 15, 1978
G-6PD loading of G-6PD-deficient erythrocytesG C Gerli, A Agostoni, G FiorelliProceedings of the National Academy of Sciences of the United States of America|February 15, 2001
Mechanism for fetal globin gene expression: role of the soluble guanylate cyclase-cGMP-dependent protein kinase pathwayT Ikuta, S Ausenda, M D CappelliniBritish Journal of Haematology|August 1, 1981
Interaction between homozygous beta (0) thalassaemia and the Swiss type of hereditary persistence of fetal haemoglobinM D Cappellini, G Fiorelli, L F BerniniVox Sanguinis|August 12, 2009
Iron overload and toxicity: the hidden risk of multiple blood transfusionsA Shander, M D Cappellini, L T GoodnoughPageof 13